HemostOD

AdipoSeeds

This biotech company develops adipose-derived mesenchymal stem cell platelets for regenerative medicine treatments and blood transfusion substitutes to assist healthcare providers and patients.

Theratome Bio

This company develops stem-cell secretome therapeutics to treat ischemic brain injury, dry eye disease and organ transplant preservation for healthcare providers and patients.

Coagulant Therapeutics

This company develops medicines to treat acute bleeding conditions, such as postpartum haemorrhage and traumatic brain injury, for patients with urgent medical needs.

ClotProtect

This therapeutics company develops a small molecule drug to treat acute bleeding and improve survival for patients suffering from trauma or undergoing surgery.

ReproGo

This regenerative medicine company develops stem cell-derived vascular cells and organoids for drug screening and treating chronic wounds and cardiovascular diseases.

TargED Biopharmaceuticals

The company develops targeted biological drugs to treat thrombotic diseases such as acute ischaemic stroke and immune-mediated thrombotic thrombocytopenic purpura for healthcare providers.

Spot Biosystems

This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.

Garuda Therapeutics

The company develops off-the-shelf blood stem cell therapies to treat patients with hematologic malignancies, sickle cell disease, and bone marrow failure disorders.